Clinical and Neuroimaging Correlation in Patients with COVID-19

Overview

Journal AJNR Am J Neuroradiol

Specialty Neurology

Date 2020 Sep 11

PMID 32912875

Citations 20

Authors

B C Yoon

K Buch

M Lang

B P Applewhite

M D Li

W A Mehan Jr

T M Leslie-Mazwi

S P Rincon

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Coronavirus disease 2019 (COVID-19) is increasingly being recognized for its multiorgan involvement, including various neurological manifestations. We examined the frequency of acute intracranial abnormalities seen on CT and/or MR imaging in patients with COVID-19 and investigated possible associations between these findings and clinical parameters, including length of hospital stay, requirement for intubation, and development of acute kidney injury.

Materials And Methods: This was a retrospective study performed at a large academic hospital in the United States. A total of 641 patients presented to our institution between March 3, 2020, and May 6, 2020, for treatment of coronavirus disease 2019, of whom, 150 underwent CT and/or MR imaging of the brain. CT and/or MR imaging examinations were evaluated for the presence of hemorrhage, infarction, and leukoencephalopathy. The frequency of these findings was correlated with clinical variables, including body mass index, length of hospital stay, requirement for intubation, and development of acute kidney injury as documented in the electronic medical record.

Results: Of the 150 patients, 26 (17%) had abnormal CT and/or MR imaging findings, with hemorrhage in 11 of the patients (42%), infarction in 13 of the patients (50%), and leukoencephalopathy in 7 of the patients (27%). Significant associations were seen between abnormal CT/MR imaging findings and intensive care unit admission ( = .039), intubation ( = .004), and acute kidney injury ( = .030).

Conclusions: A spectrum of acute neuroimaging abnormalities was seen in our cohort of patients with coronavirus disease 2019, including hemorrhage, infarction, and leukoencephalopathy. Significant associations between abnormal neuroimaging studies and markers of disease severity (intensive care unit admission, intubation, and acute kidney injury) suggest that patients with severe forms of coronavirus disease 2019 may have higher rates of neuroimaging abnormalities.

Citing Articles

Brain structures as potential mediators of the causal effect of COVID 19 on migraine risk.

Xu H, Chen W, Ju Y, Chen H, Yuan P, Ouyang F Sci Rep. 2024; 14(1):27895.

PMID: 39537835 PMC: 11560959. DOI: 10.1038/s41598-024-79530-9.

Topographical Distribution of Neuroanatomical Abnormalities Following COVID-19 Invasion : A Systematic Literature Review.

Kiyak C, Ijezie O, Ackah J, Armstrong M, Cowen J, Cetinkaya D Clin Neuroradiol. 2023; 34(1):13-31.

PMID: 37697012 PMC: 10881816. DOI: 10.1007/s00062-023-01344-5.

Neuroimaging Spectrum in COVID-19 Infection: A Single-Center Experience.

Tiwari S, Garg P, Panda S, Gupta A, Hegde A, Kumar D Indian J Radiol Imaging. 2023; 33(3):351-360.

PMID: 37362355 PMC: 10289858. DOI: 10.1055/s-0043-1768060.

Neurological manifestation in COVID-19 disease with neuroimaging studies.

Ghaderi S, Olfati M, Ghaderi M, Hadizadeh H, Yazdanpanah G, Khodadadi Z Am J Neurodegener Dis. 2023; 12(2):42-84.

PMID: 37213710 PMC: 10195392.

Neurological complications and effects of COVID-19: Symptoms and conceivable mechanisms.

Sarioglu E, Sarialtin S, Coban T Brain Hemorrhages. 2023; 4(3):154-173.

PMID: 36789140 PMC: 9911160. DOI: 10.1016/j.hest.2023.02.001.

References

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(5):2620-2629. PMC: 7190990. DOI: 10.1172/JCI137244. View

Lo E, Broderick J, Moskowitz M . tPA and proteolysis in the neurovascular unit. Stroke. 2004; 35(2):354-6. DOI: 10.1161/01.STR.0000115164.80010.8A. View

Palaiodimos L, Kokkinidis D, Li W, Karamanis D, Ognibene J, Arora S . Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020; 108:154262. PMC: 7228874. DOI: 10.1016/j.metabol.2020.154262. View

Simpson S, Kay F, Abbara S, Bhalla S, Chung J, Chung M . Radiological Society of North America Expert Consensus Document on Reporting Chest CT Findings Related to COVID-19: Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiol Cardiothorac Imaging. 2021; 2(2):e200152. PMC: 7233447. DOI: 10.1148/ryct.2020200152. View

Radmanesh A, Derman A, Lui Y, Raz E, Loh J, Hagiwara M . COVID-19-associated Diffuse Leukoencephalopathy and Microhemorrhages. Radiology. 2020; 297(1):E223-E227. PMC: 7507998. DOI: 10.1148/radiol.2020202040. View

Zhang F, Xiong Y, Wei Y, Hu Y, Wang F, Li G . Obesity predisposes to the risk of higher mortality in young COVID-19 patients. J Med Virol. 2020; 92(11):2536-2542. PMC: 7280697. DOI: 10.1002/jmv.26039. View

Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H . Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2):631-7. PMC: 7167720. DOI: 10.1002/path.1570. View

Oudkerk M, Buller H, Kuijpers D, van Es N, Oudkerk S, McLoud T . Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands. Radiology. 2020; 297(1):E216-E222. PMC: 7233406. DOI: 10.1148/radiol.2020201629. View

Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J . Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study. Am J Gastroenterol. 2020; 115(5):766-773. PMC: 7172492. DOI: 10.14309/ajg.0000000000000620. View

10.

Kass D, Duggal P, Cingolani O . Obesity could shift severe COVID-19 disease to younger ages. Lancet. 2020; 395(10236):1544-1545. PMC: 7196905. DOI: 10.1016/S0140-6736(20)31024-2. View

11.

Wang W, Tang J, Wei F . Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol. 2020; 92(4):441-447. PMC: 7167192. DOI: 10.1002/jmv.25689. View

12.

Ye M, Ren Y, Lv T . Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun. 2020; 88:945-946. PMC: 7146652. DOI: 10.1016/j.bbi.2020.04.017. View

13.

Varga Z, Flammer A, Steiger P, Haberecker M, Andermatt R, Zinkernagel A . Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395(10234):1417-1418. PMC: 7172722. DOI: 10.1016/S0140-6736(20)30937-5. View

14.

Sachs J, Gibbs K, Swor D, Sweeney A, Williams D, Burdette J . COVID-19-associated Leukoencephalopathy. Radiology. 2020; 296(3):E184-E185. PMC: 7437492. DOI: 10.1148/radiol.2020201753. View

15.

Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B . COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology. 2020; 296(2):E119-E120. PMC: 7233386. DOI: 10.1148/radiol.2020201187. View

16.

Franceschi A, Ahmed O, Giliberto L, Castillo M . Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection. AJNR Am J Neuroradiol. 2020; 41(7):1173-1176. PMC: 7357664. DOI: 10.3174/ajnr.A6595. View

17.

Mahammedi A, Saba L, Vagal A, Leali M, Rossi A, Gaskill M . Imaging of Neurologic Disease in Hospitalized Patients with COVID-19: An Italian Multicenter Retrospective Observational Study. Radiology. 2020; 297(2):E270-E273. PMC: 7587295. DOI: 10.1148/radiol.2020201933. View

18.

McKinney A, Kieffer S, Paylor R, SantaCruz K, Kendi A, Lucato L . Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging. AJR Am J Roentgenol. 2009; 193(1):192-206. DOI: 10.2214/AJR.08.1176. View

19.

Ng M, Lee E, Yang J, Yang F, Li X, Wang H . Imaging Profile of the COVID-19 Infection: Radiologic Findings and Literature Review. Radiol Cardiothorac Imaging. 2021; 2(1):e200034. PMC: 7233595. DOI: 10.1148/ryct.2020200034. View

20.

Su H, Yang M, Wan C, Yi L, Tang F, Zhu H . Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020; 98(1):219-227. PMC: 7194105. DOI: 10.1016/j.kint.2020.04.003. View